Summary of Purpose
This study is to evaluate the effect of dilitazem on the single-dose PK of BMS-986141 with parameters like Cmax, AUC(INF), and AUC(0-T).Read More →
The following dates are available for this trial. Trial information last updated on 6 October 2016.
|1 Sep 2016||30 Sep 2016||1 Nov 2016||1 Nov 2016||1 Oct 2016||Unavailable|
|Start Date||First Received||1st Completion||Completion||Verification||Results|
- Bristol-Myers Squibb Lead
- Masking: Open Label
- Purpose: Basic Science
- Endpoint: Pharmacokinetics Study
- Intervention: Single Group Assignment
- Recruiting sites have contact information. Please contact the sites directly. If there is no contact information, please email:
- First line of the email MUST contain NCT# and Site #.